Sulindac NDC 55289-930

NDC codes

FDA NDC Directory

Product NDC (as listed)55289-930Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55289-0930Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55289-930-10	55289093010	10 TABLET in 1 BOTTLE, PLASTIC (55289-930-10)Marketed from Jul 12, 2010
55289-930-20	55289093020	20 TABLET in 1 BOTTLE, PLASTIC (55289-930-20)Marketed from Jul 12, 2010
55289-930-30	55289093030	30 TABLET in 1 BOTTLE, PLASTIC (55289-930-30)Marketed from Jul 12, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sulindac
Generic name (nonproprietary): sulindac
Active ingredients: Sulindac — 200 mg/1
Dosage form: Tablet
Route: Oral
Labeler: PD-Rx Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 071795
Marketing start: Apr 3, 1990
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 55289-930_30ca698c-7fb2-9fa7-e063-6294a90abd86SPL ID 30ca698c-7fb2-9fa7-e063-6294a90abd86SPL set ID 68d4eeed-2501-494b-b979-502720de86c0RxCUI 198239UNII 184SNS8VUHUPC 0355289930105
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455289093010 followed by a unit qualifier and the quantity

Package 55289-0930-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 20, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of sulindac and other treatment options before deciding to use sulindac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Sulindac tablets, USP are indicated for acute or long-term use in the relief of signs and symptoms of the following: Osteoarthritis Rheumatoid arthritis** Ankylosing spondylitis Acute painful shoulder (Acute subacromial bursitis/supraspinatus tendinitis) Acute gouty arthritis **The safety and effectiveness of sulindac have not been established in rheumatoid arthritis patients who are designated in the American Rheumatism Asso…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 071795

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 071795
Product	Strength	Form · route	Labeler	Product NDC
Sulindac	Sulindac 200 mg/1	TabletOral	Actavis Pharma, Inc.	0591-5660